KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Procter & Gamble (PG) EBITDA (2016 - 2025)

Procter & Gamble (PG) has disclosed EBITDA for 17 consecutive years, with $5.4 billion as the latest value for Q4 2025.

  • Quarterly EBITDA fell 6.53% to $5.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.1 billion through Dec 2025, up 1.27% year-over-year, with the annual reading at $20.5 billion for FY2025, 10.28% up from the prior year.
  • EBITDA for Q4 2025 was $5.4 billion at Procter & Gamble, down from $5.9 billion in the prior quarter.
  • The five-year high for EBITDA was $5.9 billion in Q3 2025, with the low at $3.5 billion in Q2 2021.
  • Average EBITDA over 5 years is $4.7 billion, with a median of $4.5 billion recorded in 2024.
  • The sharpest move saw EBITDA decreased 7.41% in 2022, then increased 29.51% in 2024.
  • Over 5 years, EBITDA stood at $5.2 billion in 2021, then fell by 7.41% to $4.8 billion in 2022, then decreased by 7.36% to $4.4 billion in 2023, then grew by 29.51% to $5.7 billion in 2024, then decreased by 6.53% to $5.4 billion in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $5.4 billion, $5.9 billion, and $4.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.